"Validation of a gene expression-based tissue of origin test applied to poorly differentiated and undifferentiated cancers" will be presented by Federico Monzon, M.D., Methodist Hospital, Houston, TX (#ST102, Friday, November 9, 1:00-3:00 PM, Constellation and Olympic Ballroom).
About VCU and the VCU Medical Center
Virginia Commonwealth University is the largest university in Virginia and ranks among the top 100 universities in the country in sponsored research. Located on two downtown campuses in Richmond, VCU enrolls more than 31,000 students in nearly 200 certificate and degree programs in the arts, sciences and humanities. Sixty-three of the programs are unique in Virginia, many of them crossing the disciplines of VCU's 15 schools and one college. MCV Hospitals and the health sciences schools of Virginia Commonwealth University compose the VCU Medical Center, one of the nation's leading academic medical centers. For more, see http://www.vcu.edu.
About Pathwork Diagnostics
Pathwork Diagnostics, based in Sunnyvale, California, develops and
delivers genomics-based diagnostics that advance cancer care. The company
solves unmet clinical needs in oncology by using innovative technology to
harness the power of genomics information and apply it in a robust,
reproducible and reliable manner. Pathwork Diagnostics plans to deliver
FDA-cleared microarray-based diagnostic tests for oncology to the clinical
laboratory. The company's initial tests will consist of Pathwork
Diagnostics' proprietary analytics and a companion Pathchip(TM) microarray,
which runs on the proven Affymetrix instr
|SOURCE Pathwork Diagnostics|
Copyright©2007 PR Newswire.
All rights reserved